Deoxyribonuclease I en es it fr

Deoxyribonuclease I Brand names, Deoxyribonuclease I Analogs

Deoxyribonuclease I Brand Names Mixture

  • No information avaliable

Deoxyribonuclease I Chemical_Formula

C1321H1999N339O396S9

Deoxyribonuclease I RX_link

http://www.rxlist.com/cgi/generic3/pulmozyme.htm

Deoxyribonuclease I fda sheet

Deoxyribonuclease I msds (material safety sheet)

Deoxyribonuclease I Synthesis Reference

No information avaliable

Deoxyribonuclease I Molecular Weight

29253.9

Deoxyribonuclease I Melting Point

67 oC (Chan, H.K. et al., Pharm Res. 13:756-761 (1996))

Deoxyribonuclease I H2O Solubility

No information avaliable

Deoxyribonuclease I State

Liquid

Deoxyribonuclease I LogP

-0.083

Deoxyribonuclease I Dosage Forms

Solution

Deoxyribonuclease I Indication

For treatment of cystic fibrosis

Deoxyribonuclease I Pharmacology

Cystic fibrosis (CF) is a disease characterized by the retention of viscous purulent secretions in the airways. These thick secretions contribute both to reduced pulmonary function and to frequent pulmonary infection. Purulent pulmonary secretions contain very high concentrations of extracellular DNA released by degenerating leukocytes that accumulate in response to these infections. Pulmozyme hydrolyzes the DNA in sputum of CF patients and reduces sputum viscoelasticity.

Deoxyribonuclease I Absorption

No information avaliable

Deoxyribonuclease I side effects and Toxicity

No information avaliable

Deoxyribonuclease I Patient Information

BIOD00001.html

Deoxyribonuclease I Organisms Affected

Humans and other mammals